Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Plos One|November 19, 2014
Lymphotoxin-LIGHT pathway regulates the interferon signature in rheumatoid arthritisJadwiga Bienkowska, Norm Allaire, Alice Thai, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|July 16, 2013
Use of a standardized MxA protein measurement-based assay for validation of assays for the assessment of neutralizing antibodies against interferon-βMeenu Wadhwa, Meena Subramanyam, Susan Goelz, et al.
Molecular Therapy. Methods & Clinical Development|November 19, 2020
Investigational Assay for Haplotype Phasing of the Huntingtin GeneNenad Svrzikapa, Kenneth A Longo, Nripesh Prasad, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 5, 2019
Neurofilament light levels are associated with long-term outcomes in multiple sclerosisJens Kuhle, Tatiana Plavina, Christian Barro, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|December 14, 2020
Temporal profile of serum neurofilament light in multiple sclerosis: Implications for patient monitoringPeter A Calabresi, Douglas L Arnold, Dipen Sangurdekar, et al.
JAMA Network Open|November 5, 2020
Association of Serum Neurofilament Light Levels With Long-term Brain Atrophy in Patients With a First Multiple Sclerosis EpisodeTatiana Plavina, Carol M Singh, Dipen Sangurdekar, et al.
Blood|January 7, 2012
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patientsJerry S Powell, Neil C Josephson, Doris Quon, et al.
Neurology. Genetics|June 18, 2020
Genotyping single nucleotide polymorphisms for allele-selective therapy in Huntington diseaseDaniel O Claassen, Jody Corey-Bloom, E Ray Dorsey, et al.
American Journal of Respiratory and Critical Care Medicine|October 6, 2007
Partial inhibition of integrin alpha(v)beta6 prevents pulmonary fibrosis without exacerbating inflammationGerald S Horan, Susan Wood, Victor Ona, et al.
Blood|November 24, 2011
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patientsAmy D Shapiro, Margaret V Ragni, Leonard A Valentino, et al.
Pageof 3